×
About 1,808 results

ALLMedicine™ Chickenpox Center

Research & Reviews  292 results

Vaccines for measles, mumps, rubella, and varicella in children.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336
The Cochrane Database of Systematic Reviews; Di Pietrantonj C, Rivetti A et. al.

Nov 23rd, 2021 - Measles, mumps, rubella, and varicella (chickenpox) are serious diseases that can lead to serious complications, disability, and death. However, public debate over the safety of the trivalent MMR vaccine and the resultant drop in vaccination cover...

Idiopathic purpura fulminans with anti-PS antibodies in children: a multicenter case se...
https://doi.org/10.1182/bloodadvances.2021005126
Blood Advances; Theron A, Dautremay O et. al.

Nov 18th, 2021 - Idiopathic purpura fulminans (IPF) is a rare but severe pro-thrombotic coagulation disorder that can occur after chickenpox or HHV6 infection. IPF leads to an autoantibody-mediated decrease in the protein S plasma concentration. We conducted a ret...

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
https://clinicaltrials.gov/ct2/show/NCT00001125

Nov 1st, 2021 - Varicella (chickenpox) results from primary infection with VZV. Varicella, a common and usually benign illness in normal children, is more severe in HIV-infected children and may result in other conditions such as HZ (shingles). HZ is due to react...

Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenic...
https://doi.org/10.1080/21645515.2021.1975451
Human Vaccines & Immunotherapeutics; Paradis EM, Tikhonov O et. al.

Oct 28th, 2021 - Varicella (chickenpox) is a common, highly contagious disease caused by primary infection with varicella zoster virus (VZV), which can result in bacterial superinfection, central nervous system complications, and hospitalization. Stage 2 of this P...

Prevesicular herpes zoster lumbar radiculopathy with transient motor paresis: A case re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448069
Medicine Rhyu KW, Shin JH et. al.

Oct 20th, 2021 - Herpes zoster frequently causes dermatomal vesicular rash accompanied by severe neuralgia, and reaching a differential diagnosis may be challenging before the appearance of the vesicular rash. A 40-year-old male patient visited the emergency depar...

see more →

Drugs  301 results see all →

Clinicaltrials.gov  13 results

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
https://clinicaltrials.gov/ct2/show/NCT00001125

Nov 1st, 2021 - Varicella (chickenpox) results from primary infection with VZV. Varicella, a common and usually benign illness in normal children, is more severe in HIV-infected children and may result in other conditions such as HZ (shingles). HZ is due to react...

Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019
https://clinicaltrials.gov/ct2/show/NCT04609774

Feb 4th, 2021 - The Corona Virus Disease 2019 is rapidly spreading throughout the world. Aerosol is a potential transmission route. The transmission of severe acute respiratory syndrome coronavirus in humans is thought to be via at least 3 sources: 1) inhalation ...

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
https://clinicaltrials.gov/ct2/show/NCT01138215

Jul 17th, 2020 - VZV causes two clinical diseases, primary infection results in varicella (chickenpox) after which virus latent in dorsal root ganglion. Reactivation of VZV results in herpes zoster (shingles) about years or decades. Immunocompetent children, varic...

A Cross-over, Open-label, Single-group Study to Evaluate the Safety and Immunogenicity of Live Attenuated Varicella Vaccine Skyvaricella Injection (Inj.) Developed by SK Bioscience Company Limited ...
https://clinicaltrials.gov/ct2/show/NCT04384016

May 12th, 2020 - The Safety of Skyvaricella Injection: The incidence of a chickenpox-like local rash (injection site) or chickenpox-like rash (disseminated) between 1 and 6 weeks after vaccination The incidence and severity of events (local and systemic) within 30...

Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox
https://clinicaltrials.gov/ct2/show/NCT02383797

Oct 22nd, 2019 - The investigatoris will carefully select cartilage-hair hypoplasia patients unexposed to varicella (VZV) and immunize patients in a controlled manner with VZV vaccine. Patients will be selected on the basis of disease severity and the degree of im...

see more →

News  89 results

ACIP Recommends Shingrix for Younger Immunocompromised Adults; Updates Pneumococcal Vaccine Guidance
https://www.medscape.com/viewarticle/961385

Oct 21st, 2021 - The US Centers for Disease Control and Prevention Advisory Committee of Immunization Practices (ACIP) has voted to recommend Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in immunodeficient or imm...

COVID Immunity Through Infection or Vaccination: Are They Equal?
https://www.medscape.com/viewarticle/960533

Oct 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Dr. Aaron Kheriaty, a University of California-Irvine psychiatry professor, felt he didn’t need to be vaccinated against covid because he’d fallen...

Hard-Won Gains at Risk as Delta Variant Spreads: WHO
https://www.medscape.com/viewarticle/955743

Aug 2nd, 2021 - GENEVA (Reuters) — The world is at risk of losing hard-won gains in fighting COVID-19, as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective against the disease, the World Health Organization said on Friday....

Shingrix OK'd for Immunocompromised Adults
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/93760

Jul 26th, 2021 - FDA expanded the approval of Shingrix, an adjuvanted recombinant zoster vaccine, for adults at increased risk of shingles due to immunosuppression, manufacturer GlaxoSmithKline (GSK) announced on Monday. The expanded indication is for adults ages ...

Skin Reactions to COVID Vaccines Aren't Dangerous, Study Says
https://www.medscape.com/viewarticle/948953

Apr 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The Pfizer/BioNTech and Moderna coronavirus vaccines can cause several kinds of skin reactions, but these reactions go away quickly and aren't dan...

see more →

Patient Education  28 results see all →